CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION (EIN 131933825) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1947

Legal Domicile

Phone

2124550532

Tax Period

2024-07-01 to 2025-06-30

CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION, founded in 1947, is a mid-sized nonprofit in the Health Care sector that reported $54.7M in total revenue in fiscal year 2024. Revenue surged 180% from the prior year, signaling strong growth momentum. The organization ran a surplus of $29.6M, a strong 54% operating margin.

Mission

ACCELERATING BREAKTHROUGHS BY FUNDING THE MOST INNOVATIVE YOUNG CANCER RESEARCHERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $16,245,486

Program Service Revenue $0

Investment Income $37,892,118

Other Revenue $546,003

TOTAL REVENUE $54,683,607

Expense Breakdown

Grants Paid $20,170,035

Salaries & Benefits $3,063,164

Fundraising Expenses $1,854,773

Program Expenses $22,291,129

Other Expenses $1,826,419

TOTAL EXPENSES $25,059,618

Year-over-Year Comparison

	2024	2023	Change
Revenue	$54,683,607	$19,559,693	+1.8%
Expenses	$25,059,618	$25,408,684	0.0%
Net Income	$29,623,989	$-5,848,991	-6.1%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

200

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$652,293

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANDREW S RACHLEFF	CHAIR (AS OF 10/15/24)	1.0	Officer Director	$0	$0	$0
DAVID G MARSHALL	VICE CHAIR, INVESTMENTS & TREASURER (THRU 6/10/25)	1.0	Officer Director	$0	$0	$0
DAVID M BEIRNE	VICE CHAIR, BOARD DEVELOPMENT	1.0	Officer Director	$0	$0	$0
DEBORAH J COLEMAN	SECRETARY (AS OF 6/10/25)	1.0	Officer Director	$0	$0	$0
LAURENCE W COHEN	TREASURER (AS OF 10/15/24)	1.0	Officer Director	$0	$0	$0
MICHAEL L GORDON	VICE CHAIR, BOARD DEVELOPMENT (THRU 10/15/24)	1.0	Officer Director	$0	$0	$0
SANFORD W MORHOUSE ESQ	VICE CHAIR, AUDIT & SECRETARY (THRU 6/10/25)	1.0	Officer Director	$0	$0	$0
WILLIAM G KAELIN JR MD	VICE CHAIR, SCIENTIFIC PROGRAMS	1.0	Officer Director	$0	$0	$0
ADAM R SCHWARTZ	DIRECTOR	1.0	Director	$0	$0	$0
AMOOLYA SINGH PHD	DIRECTOR	1.0	Director	$0	$0	$0
BUCK FRENCH	DIRECTOR	1.0	Director	$0	$0	$0
CARLOS L ARTEAGA MD	DIRECTOR	1.0	Director	$0	$0	$0
CYNTHIA SULZBERGER	DIRECTOR	1.0	Director	$0	$0	$0
DAVID A GORDON PHD	DIRECTOR	1.0	Director	$0	$0	$0
ELAINE V FUCHS PHD	DIRECTOR	1.0	Director	$0	$0	$0
ERICA EVANS GIOFFRE	DIRECTOR	1.0	Director	$0	$0	$0
GABRIELLE LAYTON PHD	DIRECTOR	1.0	Director	$0	$0	$0
GARY E ERLBAUM	DIRECTOR	1.0	Director	$0	$0	$0
GERALD M MARSHALL	DIRECTOR	1.0	Director	$0	$0	$0
JAMES WELLS PHD	DIRECTOR	1.0	Director	$0	$0	$0
JOHN H MYERS	DIRECTOR (THRU 10/15/24)	1.0	Director	$0	$0	$0
JOSEPH PEARLBERG MD PHD	DIRECTOR	1.0	Director	$0	$0	$0
JUDY SWANSON	DIRECTOR	1.0	Director	$0	$0	$0
KAREN D SEITZ	DIRECTOR (THRU 10/15/24)	1.0	Director	$0	$0	$0
LEVI A GARRAWAY MD PHD	DIRECTOR	1.0	Director	$0	$0	$0
LORI J PIERCE MD	DIRECTOR	1.0	Director	$0	$0	$0
MELISSA L COHN	DIRECTOR	1.0	Director	$0	$0	$0
MICHAEL V SEIDEN MD PHD	DIRECTOR	1.0	Director	$0	$0	$0
MORANA JOVAN-EMBIRICOS PHD	DIRECTOR	1.0	Director	$0	$0	$0
NANCY SIMONIAN MD	DIRECTOR	1.0	Director	$0	$0	$0
NOAH KNAUF	DIRECTOR	1.0	Director	$0	$0	$0
PETER VAN CAMP	DIRECTOR	1.0	Director	$0	$0	$0
RICHARD B GAYNOR MD	DIRECTOR	1.0	Director	$0	$0	$0
RICHARD HOFFMAN	DIRECTOR	1.0	Director	$0	$0	$0
RICHARD J O'REILLY MD	DIRECTOR	1.0	Director	$0	$0	$0
RICHARD W MEIER	DIRECTOR	1.0	Director	$0	$0	$0
ROBYN COLES	DIRECTOR	1.0	Director	$0	$0	$0
SCOTT GREENSTEIN	DIRECTOR	1.0	Director	$0	$0	$0
STEVEN A KANDARIAN	DIRECTOR	1.0	Director	$0	$0	$0
STEVEN J BURAKOFF MD	DIRECTOR (THRU 10/15/24)	1.0	Director	$0	$0	$0
TODD R GOLUB MD	DIRECTOR	1.0	Director	$0	$0	$0
YUNG S LIE PHD	PRESIDENT & CEO	40.0	Officer	$592,380	$59,913	$652,293
CLARE CAHILL	CHIEF ADMINISTRATIVE OFFICER	40.0	Highest	$253,185	$36,955	$290,140
ELYSE HOFFMANN	SENIOR DIRECTOR OF STRATEGIC PARTNERSHIP	40.0	Highest	$199,837	$39,199	$239,036
KIMBERLY KUBERT	DIRECTOR OF SPECIAL EVENTS	40.0	Highest	$211,585	$35,757	$247,342
MEGAN ALLEN PHD	SCIENTIFIC DIRECTOR	40.0	Highest	$143,407	$24,343	$167,750
MEGHAN MCCURDY	DIRECTOR OF COMMUNICATIONS & MARKETING	40.0	Highest	$157,037	$43,527	$200,564

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$54,683,607	$25,059,618	$170,380,475	$29,623,989
2024	$19,559,693	$25,408,684	$160,511,709	$-5,848,991
2023	$15,715,675	$21,219,216	$147,680,687	$-5,503,541
2022	$14,385,319	$21,596,927	$143,543,813	$-7,211,608
2021	$20,562,891	$20,352,745	$175,580,654	$210,146
2020	$54,248,600	$23,330,168	$148,107,071	$30,918,432
2019	$21,005,283	$25,301,097	$150,535,887	$-4,295,814
2018	$21,568,069	$21,204,617	$148,707,992	$363,452

CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION